Adenosine Concentration in Patients With Neurally Mediated Syncope

Antonella Groppelli; Michele Brignole; Mohamed Chefrour; Marguerite Gastaldi; Farid El Oufir; Jean‐Claude Deharo; Gianfranco Parati; Régis Guieu

doi:10.3389/fcvm.2022.900023

Abstract

1 min read

ABL is different in patients with suspected NMS than in healthy subjects. Patients with low and high adenosine values account for 19% and 18% of the general population. Thus, low and high ABL limits, as defined in this study, may help to define the purinergic profile of unselected subjects with a clinical diagnosis of suspected NMS.

Related publications

Article2020

Plasma adenosine and neurally mediated syncope: ready for clinical use

Michele Brignole, Antonella Groppelli, Roberto Brambilla, Gianluca Caldara, Erminio Torresani, Gianfranco Parati, Diana Solari, Andrea Ungar, Martina Rafanelli, Jean‐Claude Deharo, Marion Marlinge, Mohamed Chefrour, Regis Guieu

Article2016

Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism

Kittipong Maneechotesuwan, Kanda Kasetsinsombat, Adisak Wongkajornsilp, Peter J Barnes

Article2023

Targeting the ATP-Axis in Lungs as a New Therapheutic Modality for COPD

Amir Pelleg, Peter J Barnes, Edward S. Schulman

Article2023

EEG correlates in the three variants of Primary Progressive Aphasia

Giordano Cecchetti, Federica Agosta, Silvia Basaia, Camilla Cividini, Marco Cursi, Elisa Canu, Michela Leocadi, Roberto Santangelo, Francesca Caso, Giovanna Franca Fanelli, Fabio Minicucci, Giuseppe Magnani, Massimo Filippi

Article2022

New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)

Giulia Rivasi, Michele Brignole, Antonella Groppelli, Davide Soranna, Antonella Zambon, Rachel E. Sutton, Rose Anne Kenny, Andrea Ungar, Artur Fedorowski, Gianfranco Parati